LC
BSX icon

Lindbrook Capital’s Boston Scientific BSX Stock Holding History

Lindbrook Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$696K Buy
6,897
+1,186
+21% +$119K 0.06% 173
2024
Q4 		$510K Buy
5,711
+94
+2% +$8.28K 0.05% 215
2024
Q3 		$471K Sell
5,617
-32
-0.6% -$2.52K 0.04% 225
2024
Q2 		$435K Sell
5,649
-144
-2% -$10.5K 0.04% 227
2024
Q1 		$397K Buy
5,793
+182
+3% +$11.7K 0.04% 242
2023
Q4 		$324K Buy
5,611
+1,924
+52% +$103K 0.03% 260
2023
Q3 		$195K Buy
3,687
+211
+6% +$11.1K 0.02% 321
2023
Q2 		$188K Buy
3,476
+1
+0% +$52 0.02% 337
2023
Q1 		$174K Buy
3,475
+1,442
+71% +$68K 0.02% 345
2022
Q4 		$94.1K Sell
2,033
-9,966
-83% -$432K 0.01% 505
2022
Q3 		$465K Buy
11,999
+321
+3% +$12.9K 0.08% 151
2022
Q2 		$435K Buy
11,678
+119
+1% +$4.84K 0.07% 168
2022
Q1 		$512K Sell
11,559
-180
-2% -$7.8K 0.08% 158
2021
Q4 		$499K Buy
11,739
+80
+0.7% +$3.36K 0.08% 166
2021
Q3 		$506K Buy
11,659
+8
+0.1% +$354 0.13% 67
2021
Q2 		$498K Buy
11,651
+35
+0.3% +$1.47K 0.11% 79
2021
Q1 		$449K Buy
11,616
+263
+2% +$9.95K 0.1% 81
2020
Q4 		$408K Buy
11,353
+16
+0.1% +$577 0.1% 84
2020
Q3 		$433K Buy
11,337
+42
+0.4% +$1.62K 0.12% 67
2020
Q2 		$397K Sell
11,295
-313
-3% -$11.3K 0.12% 71
2020
Q1 		$379K Sell
11,608
-863
-7% -$33.7K 0.14% 59
2019
Q4 		$564K Sell
12,471
-55
-0.4% -$2.3K 0.2% 50
2019
Q3 		$510K Buy
12,526
+123
+1% +$5.21K 0.19% 48
2019
Q2 		$533K Buy
12,403
+45
+0.4% +$1.73K 0.21% 47
2019
Q1 		$474K Buy
12,358
+99
+0.8% +$3.78K 0.19% 51
2018
Q4 		$433K Buy
+12,259
New +$445K 0.21% 49

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Lindbrook Capital's BSX Position: Q1 2025 in Review

Lindbrook Capital increased its Boston Scientific (BSX) stake by 21% in Q1 2025, buying an estimated $119K and bringing the position to 6,897 shares worth $696K. The position accounts for 0.06% of the portfolio, ranked #173.

Lindbrook Capital first reported a position in BSX in Q4 2018 and has held it in 26 quarters since. 1,644 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Lindbrook Capital held 6,897 shares of Boston Scientific worth $696K as of Q1 2025.
  • Lindbrook Capital bought 1,186 Boston Scientific shares in Q1 2025, an estimated $119K.
  • Boston Scientific made up 0.06% of Lindbrook Capital's portfolio in Q1 2025, its #173 holding.
  • Lindbrook Capital first reported a position in Boston Scientific in Q4 2018 and has held it in 26 quarters since.
  • 1,644 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.